Related references
Note: Only part of the references are listed.Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma The CheckMate 143 Phase 3 Randomized Clinical Trial
David A. Reardon et al.
JAMA ONCOLOGY (2020)
Oncolytic Viruses and the Immune System: The Dynamic Duo
Ana Lemos de Matos et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Turning Cold into Hot: Firing up the Tumor Microenvironment
Qianqian Duan et al.
TRENDS IN CANCER (2020)
Oncolytic viruses: overcoming translational challenges
Jordi Martinez-Quintanilla et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Timothy F. Cloughesy et al.
NATURE MEDICINE (2019)
Modeling Patient-Derived Glioblastoma with Cerebral Organoids
Amanda Linkous et al.
CELL REPORTS (2019)
The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models
Naiara Martinez-Velez et al.
NATURE COMMUNICATIONS (2019)
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
E. Antonio Chiocca et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma
Juri Kiyokawa et al.
ONCOLYTIC VIROTHERAPY (2019)
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F. Lang et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Annick Desjardins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Organoid Modeling of the Tumor Immune Microenvironment
James T. Neal et al.
CELL (2018)
The Sequence of Delta24-RGD and TMZ Administration in Malignant Glioma Affects the Role of CD8+T Cell Anti-tumor Activity
Anne Kleijn et al.
MOLECULAR THERAPY-ONCOLYTICS (2017)
Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination
Hong Jiang et al.
CANCER RESEARCH (2017)
Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas
Brittany C. Parker Kerrigan et al.
CYTOTHERAPY (2017)
Tumor-Associated Macrophages in Oncolytic Virotherapy: Friend or Foe?
Nicholas L. Denton et al.
BIOMEDICINES (2016)
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H. I. Andtbacka et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Going viral: a review of replication-selective oncolytic adenoviruses
Christopher Larson et al.
ONCOTARGET (2015)
A novel immunocompetent murine model for replicating oncolytic adenoviral therapy
L. Zhang et al.
CANCER GENE THERAPY (2015)
The In Vivo Therapeutic Efficacy of the Oncolytic Adenovirus Delta24-RGD Is Mediated by Tumor-Specific Immunity
Anne Kleijn et al.
PLOS ONE (2014)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
A Preclinical Evaluation of Neural Stem CellBased Cell Carrier for Targeted Antiglioma Oncolytic Virotherapy
Atique U. Ahmed et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
N-acetylcysteine Amide Augments the Therapeutic Effect of Neural Stem Cell-Based Antiglioma Oncolytic Virotherapy
Chung Kwon Kim et al.
MOLECULAR THERAPY (2013)
NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors
Christopher A. Alvarez-Breckenridge et al.
NATURE MEDICINE (2012)
Genetically Engineered Mouse Models of Brain Cancer and the Promise of Preclinical Testing
Jason T. Huse et al.
BRAIN PATHOLOGY (2009)
Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats
A. M. Sonabend et al.
CANCER GENE THERAPY (2009)
Human Bone Marrow-Derived Mesenchymal Stem Cells for Intravascular Delivery of Oncolytic Adenovirus Delta 24-RGD to Human Gliomas
Raymund L. Yong et al.
CANCER RESEARCH (2009)
Design and application of oncolytic HSV vectors for glioblastoma therapy
Paola Grandi et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo
M. A. Tyler et al.
GENE THERAPY (2009)
Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma
Adam M. Sonabend et al.
STEM CELLS (2008)
Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter
Marta M. Alonso et al.
CANCER RESEARCH (2007)
Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses
Giulia Fulci et al.
CANCER RESEARCH (2007)
Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: Role of autophagic, cell death
Hong Jiang et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Andrew T. Parsa et al.
NATURE MEDICINE (2007)
Use of replicating oncolytic adenoviruses in combination therapy for cancer
RL Chu et al.
CLINICAL CANCER RESEARCH (2004)
Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway
J Fueyo et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas
KS Aboody et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
J Fueyo et al.
ONCOGENE (2000)
Share Paper
